Advancements in the Synthesis of Triazolopyrimidines

References

1. NedaI. KaukoratT. SchmutzlerR. Verbindungen mit dem 1,3,2 benzodiazaphosphorinan 4 on grundgerüst: synthese von neuartigen n,n′,n′ trimethylethylendiaminsubstituierten derivaten mit drei und vierfach koordiniertem phosphor.Phosphorus Sulfur Silicon Relat. Elem.1993801-424125010.1080/10426509308036896
   [Google Scholar]
2. NedaI. FischerA. JonesP.G. SchmutzlerR. Verbindungen mit dem 1,3,2 benzodiazaphosphorinan 4 on grundgerüst: synthese von neuartigen, n,n dimethyl amino und bis 2 chlorethylamino-substituierten derivaten mit drei, vier und fünffach koordiniertem phosphor.Phosphorus Sulfur Silicon Relat. Elem.1993781-427128710.1080/10426509308032443
   [Google Scholar]
3. FarkensM. NedaI. FischerA. JonesP.G. SchmutzlerR. ChemInform abstract: Chemistry of the 1,3,5 Triaza 2 phosphinane 4,6 diones. Part 4. Hydrolysis of and thermal elimination from 1,3,5 Triaza 2λ4 phosphinimide 4,6 diones and 1,3,5 Triaza 1,4 dioxa 5λ5 phosphaspiro(4.5)decane 7,9 diones. ChemInform19932445 chin.199345249.10.1002/chin.199345249
   [Google Scholar]
4. KadyrovA. NedaI. KaukoratT. SonnenburgR. FischerA. JonesP.G. SchmutzlerR. Neue phospholen und phosphepin derivate aus λ3 phosphorverbindungen und hexafluoraceton oder perfluorierten α diketonen.Chem. Ber.1996129672573210.1002/cber.19961290620
   [Google Scholar]
5. MafteiC.V. FodorE. JonesP.G. DaniliucC.G. FranzM.H. KelterG. FiebigH.H. TammM. NedaI. Novel 1,2,4-oxadiazoles and trifluoromethylpyridines related to natural products: synthesis, structural analysis and investigation of their antitumor activity.Tetrahedron20167291185119910.1016/j.tet.2016.01.011
   [Google Scholar]
6. MafteiE. MafteiC.V. JonesP.G. FreytagM. FranzM.H. KelterG. FiebigH.H. TammM. NedaI. Trifluoromethylpyridine-substituted N-heterocyclic carbenes related to natural products: synthesis, structure, and potential antitumor activity of some corresponding gold(I), rhodium(I), and iridium(I) complexes.Helv. Chim. Acta201699646948110.1002/hlca.201500529
   [Google Scholar]
7. MafteiC.V. FodorE. JonesP.G. FranzM.H. KelterG. FiebigH. NedaI. Synthesis and characterization of novel bioactive 1,2,4-oxadiazole natural product analogs bearing the N-phenylmaleimide and N-phenylsuccinimide moieties.Beilstein J. Org. Chem.201392202221510.3762/bjoc.9.259 24222789
   [Google Scholar]
8. MalikM.A. DarO.A. GullP. WaniM.Y. HashmiA.A. Heterocyclic Schiff base transition metal complexes in antimicrobial and anticancer chemotherapy.MedChemComm20189340943610.1039/C7MD00526A 30108933
   [Google Scholar]
9. KhoseV. JohnM. PandeyA. BorovkovV. KarnikA. Chiral heterocycle-based receptors for enantioselective recognition.Symmetry (Basel)20181023410.3390/sym10020034
   [Google Scholar]
10. SharmaM. PandeyV. PoliG. TuccinardiT. LolliM.L. VyasV.K. A comprehensive review of synthetic strategies and SAR studies for the discovery of PfDHODH inhibitors as antimalarial agents. Part 1: triazolopyrimidine, isoxazolopyrimidine and pyrrole-based (DSM) compounds.Bioorg. Chem.202414610724910.1016/j.bioorg.2024.107249 38493638
    [Google Scholar]
11. MyersS.H. PoppiL. RinaldiF. VeronesiM. CiamaroneA. PrevitaliV. BagnoliniG. SchipaniF. Ortega MartínezJ.A. GirottoS. Di StefanoG. FarabegoliF. WalshN. De FrancoF. RobertiM. CavalliA. An 19F NMR fragment-based approach for the discovery and development of BRCA2-RAD51 inhibitors to pursuit synthetic lethality in combination with PARP inhibition in pancreatic cancer.Eur. J. Med. Chem.202426511611410.1016/j.ejmech.2023.116114 38194775
    [Google Scholar]
12. MousaviH. A comprehensive survey upon diverse and prolific applications of chitosan-based catalytic systems in one-pot multi-component synthesis of heterocyclic rings.Int. J. Biol. Macromol.20211861003116610.1016/j.ijbiomac.2021.06.123 34174311
    [Google Scholar]
13. MohiteP. NaharD. PawaraR. AlqahtaniT. EldinS.M. MukherjeN. Rahman Mohammad Said Al-TawahaA. IqbalR. BawazeerS. AliI. Triazolopyridine, a leitmotif of synthetic methods and pharmacological attributes: An extensive review.Arab. J. Chem.2023161010518110.1016/j.arabjc.2023.105181
    [Google Scholar]
14. KerruN. GummidiL. MaddilaS. GanguK.K. JonnalagaddaS.B. A review on recent advances in nitrogen-containing molecules and their biological applications.Molecules2020258190910.3390/molecules25081909 32326131
    [Google Scholar]
15. FeitosaL.M. FrancaR.R.F. FerreiraM.L.G. AguiarA.C.C. de SouzaG.E. MalufS.E.C. de SouzaJ.O. ZapataL. DuarteD. MoraisI. NogueiraF. NonatoM.C. PinheiroL.C.S. GuidoR.V.C. BoechatN. Discovery of new piperaquine hybrid analogs linked by triazolopyrimidine and pyrazolopyrimidine scaffolds with antiplasmodial and transmission blocking activities.Eur. J. Med. Chem.202426711616310.1016/j.ejmech.2024.116163 38290351
    [Google Scholar]
16. Abu-HashemA.A. Al-HussainS.A. The synthesis, antimicrobial activity, and molecular docking of new 1, 2, 4-triazole, 1, 2, 4-triazepine, quinoline, and pyrimidine scaffolds condensed to naturally occurring furochromones.Pharmaceuticals (Basel)20221510123210.3390/ph15101232 36297343
    [Google Scholar]
17. AbdelhamidA.E. KhattabR.R. SwelamS.A. SolimanA.M. Abd El-MoezS.I. BelasyS.F. El-SayedA.A. Antimicrobial evaluation of composite films based on polyvinyl alcohol/triazolopyrimidenes/selenium nanoparticles.Egyptian Pharmaceutical Journal2024231354510.4103/epj.epj_172_23
    [Google Scholar]
18. AbdelkhalekA.S. AttiaM.S. KamalM.A. Triazolopyrimidine derivatives: An updated review on recent advances in synthesis, biological activities and drug delivery aspects.Curr. Med. Chem.202330124 36852819
    [Google Scholar]
19. PundeerR. SinghS. YadavS. MinakshiM. Green synthesis of pyrazoles: recent developments in aqueous methods.SynOpen20237329731210.1055/a‑2123‑8102
    [Google Scholar]
20. SinghS. PrakashR. DuaN. SharmaC. PundeerR. Some new pyrazolyl pyrazolones and cyanopyrazolyl acrylates: Design, synthesis and biological evaluation.ChemistrySelect20194236849685310.1002/slct.201900118
    [Google Scholar]
21. FischerG. 1,2,4-Triazolo[1,5-a]pyrimidines. In: Advances in Heterocyclic Chemistry; Elsevier, 1993578113810.1016/S0065‑2725(08)60887‑9
    [Google Scholar]
22. FischerG. Recent progress in 1,2,4-triazolo[1,5-a]pyrimidine chemistry. In: Advances in Heterocyclic Chemistry; Elsevier, 20079514321910.1016/S0065‑2725(07)95003‑5
    [Google Scholar]
23. FischerG. Recent advances in 1,2,4-triazolo[1,5-a]pyrimidine chemistry In: Advances in Heterocyclic Chemistry; Elsevier2019128110110.1016/bs.aihch.2018.10.002
    [Google Scholar]
24. EdreesM.M. FarghalyT.A. Synthesis and antitumor activity of benzo[6″,7″]cyclohepta[1″,2″:4′,5′]pyrido[2′,3′-d][1,2,4]triazolo[4,3-a]pyrimidin-5-ones.Arab. J. Chem.201710S1613S161810.1016/j.arabjc.2013.06.002
    [Google Scholar]
25. El AshryE.S.H. AwadL.F. TelebM. IbrahimN.A. Abu-SerieM.M. Abd Al MoatyM.N. Structure-based design and optimization of pyrimidine- and 1,2,4-triazolo[4,3-a]pyrimidine-based matrix metalloproteinase-10/13 inhibitors via Dimroth rearrangement towards targeted polypharmacology.Bioorg. Chem.20209610361610.1016/j.bioorg.2020.103616 32032847
    [Google Scholar]
26. HorchaniM. HajlaouiA. HarrathA.H. MansourL. Ben JannetH. RomdhaneA. New pyrazolo-triazolo-pyrimidine derivatives as antibacterial agents: Design and synthesis, molecular docking and DFT studies.J. Mol. Struct.2020119912700710.1016/j.molstruc.2019.127007
    [Google Scholar]
27. BülowC. HaasK. Synthetische versuche zur darstellung von derivaten des heterokondensierten, heterocyclischen 1.3‐triazo‐7.0′‐pyrimidins.Ber. Dtsch. Chem. Ges.19094244638464410.1002/cber.19090420468
    [Google Scholar]
28. TenorE. LudwigR. Drug chemical studies of the s-triazolo-1.5-a-pyrimidine series. Die Pharmazie1971534539
    [Google Scholar]
29. FüllerH. HauschildF. ModersohnD. ThomasE. Pharmacology of 6-methyl-7-diethylamino-s-triazolo-(1, 5-a) pyrimidine (Trapymin, Rocornal), a new compound with vasodilative effects. Die Pharmazie1971269554562
    [Google Scholar]
30. WatanabeI. OkumuraY. NagashimaK. KofuneM. OhkuboK. ManoH. SonodaK. KasamakiY. HirayamaA. Effects of the antianginal drug trapidil on atrioventricular conduction disturbances during acute myocardial ischemia.Int. Heart J.201253318719210.1536/ihj.53.187 22790688
    [Google Scholar]
31. LiH. TatlockJ. LintonA. GonzalezJ. JewellT. PatelL. LudlumS. DrownsM. RahavendranS.V. SkorH. HunterR. ShiS.T. HerlihyK.J. PargeH. HickeyM. YuX. ChauF. NonomiyaJ. LewisC. Discovery of (R)-6-Cyclopentyl-6-(2-(2,6-diethylpyridin-4-yl)ethyl)-3-((5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)methyl)-4-hydroxy-5,6-dihyd-ropyran-2-one (PF-00868554) as a potent and orally available hepatitis C] virus polymerase inhibitor.J. Med. Chem.20095251255125810.1021/jm8014537 19209845
    [Google Scholar]
32. SingerR.A. RaganJ.A. BowlesP. ChisowaE. ConwayB.G. CordiE.M. LeemanK.R. LetendreL.J. SieserJ.E. SluggettG.W. StanchinaC.L. StrohmeyerH. BluntJ. TaylorS. ByrneC. LynchD. MullaneS. O’SullivanM.M. WhelanM. Synthesis of filibuvir. part I. Diastereoselective preparation of a β-hydroxy alkynyl oxazolidinone and conversion to a 6,6-disubstituted 2H-pyranone.Org. Process Res. Dev.2014181263510.1021/op4002356
    [Google Scholar]
33. FandzlochM. AugustyniakA.W. DobrzańskaL. JędrzejewskiT. SitkowskiJ. WypijM. GolińskaP. First dinuclear rhodium(II) complexes with triazolopyrimidines and the prospect of their potential biological use.J. Inorg. Biochem.202021011107210.1016/j.jinorgbio.2020.111072 32563102
    [Google Scholar]
34. RutaL.L. FarcasanuI.C. BacalumM. RăileanuM. RostasA.M. DaniliucC. ChifiriucM.C. MăruțescuL. PopaM. BadeaM. IorgulescuE.E. OlarR. Biological activity of triazolopyrimidine copper(II) complexes modulated by an auxiliary N-N-chelating heterocycle ligands.Molecules20212622677210.3390/molecules26226772 34833864
    [Google Scholar]
35. HanL.R. ChengL. HuD.S. ChenQ.W. HanL. XuT.M. LiuX.H. WuN.J. Design, synthesis and biological activities of 1,2, 4‐triazolo[1,5‐a]pyrimidine‐7‐amine derivatives bearing 1,2, 4‐oxadiazole motif.J. Heterocycl. Chem.202360224125110.1002/jhet.4576
    [Google Scholar]
36. LowY.S. GarciaM.D. LonhienneT. FraserJ.A. SchenkG. GuddatL.W. Triazolopyrimidine herbicides are potent inhibitors of Aspergillus fumigatus acetohydroxyacid synthase and potential antifungal drug leads.Sci. Rep.20211112105510.1038/s41598‑021‑00349‑9 34702838
    [Google Scholar]
37. SaundaneA.R. HaluA. KirankumarN.M. Synthesis and biological evaluation of some novel indole analogues containing triazolopyrimidine moiety.Monatsh. Chem.201714881497151110.1007/s00706‑017‑1957‑1
    [Google Scholar]
38. GadaraS.A. LadvaK.D. Solid phase synthesis and antimicrobial activity of novel triazolo[1,5-a]pyrimidine derivatives.Asian J. Chem.20203292298230210.14233/ajchem.2020.22793
    [Google Scholar]
39. RenyuQ. YuchaoL. KandegamaW.M.W.W. QiongC. GuangfuY. Recent applications of triazolopyrimidine-based bioactive compounds in medicinal and agrochemical chemistry.Mini Rev. Med. Chem.201818978179310.2174/1389557517666171101112850
    [Google Scholar]
40. IbrahimZ.Y. UzairuA. ShallangwaG. AbechiS. In-silico design of aryl and aralkyl amine-based triazolopyrimidine derivatives with enhanced activity against resistant Plasmodium falciparum.Chemistry Africa20214113714810.1007/s42250‑020‑00199‑4
    [Google Scholar]
41. ChowdharyS. Shalini; Mosnier, J.; Fonta, I.; Pradines, B.; Cele, N.; Seboletswe, P.; Singh, P.; Kumar, V. Synthesis, Anti-plasmodial activities, and mechanistic insights of 4-aminoquinoline-triazolopyrimidine hybrids.ACS Med. Chem. Lett.20221371068107610.1021/acsmedchemlett.2c00078 35859870
    [Google Scholar]
42. PhillipsM.A. GujjarR. MalmquistN.A. WhiteJ. El MazouniF. BaldwinJ. RathodP.K. Triazolopyrimidine-based dihydroorotate dehydrogenase inhibitors with potent and selective activity against the malaria parasite Plasmodium falciparum.J. Med. Chem.200851123649365310.1021/jm8001026 18522386
    [Google Scholar]
43. GujjarR. MarwahaA. El MazouniF. WhiteJ. WhiteK.L. CreasonS. ShacklefordD.M. BaldwinJ. CharmanW.N. BucknerF.S. CharmanS. RathodP.K. PhillipsM.A. Identification of a metabolically stable triazolopyrimidine-based dihydroorotate dehydrogenase inhibitor with antimalarial activity in mice.J. Med. Chem.20095271864187210.1021/jm801343r 19296651
    [Google Scholar]
44. GiganteA. Gómez-SanJuanA. DelangL. LiC. BuenoO. GamoA.M. PriegoE.M. CamarasaM.J. JochmansD. LeyssenP. DecrolyE. CoutardB. QueratG. NeytsJ. Pérez-PérezM.J. Antiviral activity of [1,2,3]triazolo[4,5-d]pyrimidin-7(6H)-ones against chikungunya virus targeting the viral capping nsP1.Antiviral Res.201714421622210.1016/j.antiviral.2017.06.003 28619679
    [Google Scholar]
45. BaklykovA.V. RusinovG.L. Artem’evG.A. KopchukD.S. ZyryanovG.V. RusinovV.L. CharushinV.N. Synthesis of 5-methyl-1,2,4-triazolo[1,5-a]pyrimidin-7(4H)-one - a semi-product of the synthesis of antiviral drug triazide® in the conditions of microwave excitation. AIP Conf. Proc.,2019206304000510.1063/1.5087337
    [Google Scholar]
46. HuangB. KangD. TianY. DaelemansD. De ClercqE. PannecouqueC. ZhanP. LiuX. Design, synthesis, and biological evaluation of piperidinyl‐substituted [1,2,4]triazolo[1,5‐a]pyrimidine derivatives as potential anti‐HIV‐1 agents with reduced cytotoxicity.Chem. Biol. Drug Des.2021971677610.1111/cbdd.13760 32725669
    [Google Scholar]
47. PinheiroS. PinheiroE.M.C. MuriE.M.F. PessôaJ.C. CadoriniM.A. GrecoS.J. Biological activities of [1,2,4]triazolo[1,5-a]pyrimidines and analogs.Med. Chem. Res.202029101751177610.1007/s00044‑020‑02609‑1
    [Google Scholar]
48. OzbekE.N. IstanbulluH. KızrakU. Alan AlbayrakE. SevinG. Yetik-AnacakG. The effects of novel triazolopyrimidine derivatives on H2S production in lung and vascular tonus in aorta.Pharmacology2023108653053910.1159/000533419 37696255
    [Google Scholar]
49. SaidS.A. AmrA.E.G.E. SabryN.M. AbdallaM.M. Analgesic, anticonvulsant and anti-inflammatory activities of some synthesized benzodiazipine, triazolopyrimidine and bis-imide derivatives.Eur. J. Med. Chem.200944124787479210.1016/j.ejmech.2009.07.013 19682771
    [Google Scholar]
50. YuG.X. HuY. ZhangW.X. TianX.Y. ZhangS.Y. ZhangY. YuanS. SongJ. Design, synthesis and biological evaluation of [1,2,4]triazolo[1,5-a]pyrimidine Indole derivatives against gastric cancer cells MGC-803 via the suppression of ERK signaling pathway.Molecules20222715499610.3390/molecules27154996 35956943
    [Google Scholar]
51. KohandelO. Sheikhi-MohammarehS. OroojalianF. MemarianiT. MagueJ. ShiriA. A Dimroth rearrangement approach for the synthesis of selenopheno[2,3-e][1,2,4]triazolo[1,5-c]pyrimidines with cytotoxic activity on breast cancer cells.Mol. Divers.20222631621163310.1007/s11030‑021‑10290‑8 34357512
    [Google Scholar]
52. WiśniewskaJ. FandzlochM. ŁakomskaI. The reduction of ruthenium(III) complexes with triazolopyrimidine ligands by ascorbic acid and mechanistic insight into their action in anticancer therapy.Inorg. Chim. Acta201948430531010.1016/j.ica.2018.09.051
    [Google Scholar]
53. Sáez-CalvoG. SharmaA. BalaguerF.A. BarasoainI. Rodríguez-SalarichsJ. OliericN. Muñoz-HernándezH. BerbísM.Á. WendebornS. PeñalvaM.A. MatesanzR. CanalesÁ. ProtaA.E. Jímenez-BarberoJ. AndreuJ.M. LamberthC. SteinmetzM.O. DíazJ.F. Triazolopyrimidines are microtubule-stabilizing agents that bind the vinca inhibitor site of tubulin.Cell Chem. Biol.2017246737750.e610.1016/j.chembiol.2017.05.016 28579361
    [Google Scholar]
54. HassanG.S. El-SherbenyM.A. El-AshmawyM.B. BayomiS.M. MaaroufA.R. BadriaF.A. Synthesis and antitumor testing of certain new fused triazolopyrimidine and triazoloquinazoline derivatives.Arab. J. Chem.201710S1345S135510.1016/j.arabjc.2013.04.002
    [Google Scholar]
55. MokariyaJ.A. RajaniD.P. PatelM.P. 1,2,4‐Triazole and benzimidazole fused dihydropyrimidine derivatives: Design, green synthesis, antibacterial, antitubercular, and antimalarial activities.Arch. Pharm. (Weinheim)20233564220054510.1002/ardp.202200545 36534897
    [Google Scholar]
56. UmarT. GusainS. RazaM.K. ShaliniS. KumarJ. TiwariM. HodaN. Naphthalene-triazolopyrimidine hybrid compounds as potential multifunctional anti-Alzheimer’s agents.Bioorg. Med. Chem.201927143156316610.1016/j.bmc.2019.06.004 31176571
    [Google Scholar]
57. JameelE. MeenaP. MaqboolM. KumarJ. AhmedW. MumtazuddinS. TiwariM. HodaN. JayaramB. Rational design, synthesis and biological screening of triazine-triazolopyrimidine hybrids as multitarget anti-Alzheimer agents.Eur. J. Med. Chem.2017136365110.1016/j.ejmech.2017.04.064 28478343
    [Google Scholar]
58. ShawS.A. VokitsB.P. DilgerA.K. VietA. ClarkC.G. AbellL.M. LockeG.A. DukeG. KopchoL.M. DongreA. GaoJ. KrishnakumarA. JusufS. KhanJ. SpronkS.A. BassoM.D. ZhaoL. CantorG.H. OnoratoJ.M. WexlerR.R. DuclosF. KickE.K. Discovery and structure activity relationships of 7-benzyl triazolopyridines as stable, selective, and reversible inhibitors of myeloperoxidase.Bioorg. Med. Chem.2020282211572310.1016/j.bmc.2020.115723 33007547
    [Google Scholar]
59. ChenC.N. ChenQ. LiuY.C. ZhuX.L. NiuC.W. XiZ. YangG.F. Syntheses and herbicidal activity of new triazolopyrimidine-2-sulfonamides as acetohydroxyacid synthase inhibitor.Bioorg. Med. Chem.201018144897490410.1016/j.bmc.2010.06.015 20598554
    [Google Scholar]
60. LiuY-C. QuR-Y. ChenQ. YangJ.-F. Cong-WeiN. ZhenX. YangG.F. Triazolopyrimidines as a new herbicidal lead for combating weed resistance associated with acetohydroxyacid synthase mutation.J. Agric. Food Chem.64244845485710.1021/acs.jafc.6b00720
    [Google Scholar]
61. OukoloffK. LuceroB. FranciscoK.R. BrundenK.R. BallatoreC. 1,2,4-Triazolo[1,5-a]pyrimidines in drug design.Eur. J. Med. Chem.201916533234610.1016/j.ejmech.2019.01.027 30703745
    [Google Scholar]
62. Méndez-ArriagaJ.M. OyarzabalI. EscolanoG. Rodríguez-DiéguezA. Sánchez-MorenoM. SalasJ.M. In vitro leishmanicidal and trypanocidal evaluation and magnetic properties of 7-amino-1,2,4-triazolo[1,5-a]pyrimidine Cu(II) complexes.J. Inorg. Biochem.2018180263210.1016/j.jinorgbio.2017.11.027 29227923
    [Google Scholar]
63. Méndez-ArriagaJ.M. Rodríguez-DiéguezA. Sánchez-MorenoM. In vitro leishmanicidal activity of copper (II) 5,7-dimethyl-1,2,4-triazolo[1,5-a]pyrimidine complex and analogous transition metal series.Polyhedron202017611427210.1016/j.poly.2019.114272
    [Google Scholar]
64. ŁakomskaI. FandzlochM. Application of 1,2,4-triazolo[1,5-a]pyrimidines for the design of coordination compounds with interesting structures and new biological properties.Coord. Chem. Rev.2016327-32822124110.1016/j.ccr.2016.04.014
    [Google Scholar]
65. JrR.O.R. LampenJ.O. EnglishJ.P. ColeQ.P. JrJ.R.V. Studies in chemotherapy. VIII. Methionine and purine antagonists and their relation to the sulfonamides.J. Am. Chem. Soc.67229029410.1021/ja01218a043
    [Google Scholar]
66. SinghP.K. ChoudharyS. KashyapA. VermaH. KapilS. KumarM. AroraM. SilakariO. An exhaustive compilation on chemistry of triazolopyrimidine: A journey through decades.Bioorg. Chem.20198810291910.1016/j.bioorg.2019.102919 31026721
    [Google Scholar]
67. SalemM.A. BehaloM.S. KhidreR.E. Recent trend in the chemistry of triazolopyrimidines and their applications.Mini Rev. Org. Chem.20211881134114910.2174/1570193X18666210203155358
    [Google Scholar]
68. RagabS.S. IbrahimN.E. Abdel-AzizM.S. ElrashedyA.A. AllayehA.K. Synthesis, biological activity, and molecular dynamic studies of new triazolopyrimidine derivatives.Results Chem.2023610116310.1016/j.rechem.2023.101163
    [Google Scholar]
69. HibotA. OumessaoudA. HafidA. KhouiliM. PujolM.D. Different synthetic methods for the preparation of triazolopyrimidines and their biological profile.ChemistrySelect2023823e20230165410.1002/slct.202301654
    [Google Scholar]
70. AckerD. CastleJ. Notes - A convenient laboratory synthesis of certain 6-hydroxypurines and 7-hydroxy-v-triazolo [d]pyrimidines.J. Org. Chem.195823122010201110.1021/jo01106a616
    [Google Scholar]
71. PolikarchukV.A. ChertovaY.V. PotapovA.Y. LedenyovaI.V. KoshelevaY.A. KrysinM.Y. KozadyorovO.A. ShatalovG.V. VandyshevD.Y. ShikhalievK.S. PrabhakarC. Novel variants of the multicomponent reaction for the synthesis of 1,2,4-triazolo[1,5-a]pyrimidines and pyrido[3,4-e][1,2,4]triazolo[1,5-a]pyrimidines.Chem. Heterocycl. Compd.20205681054106110.1007/s10593‑020‑02773‑7
    [Google Scholar]
72. MohamedM.A.A. BekhitA.A. Abd AllahO.A. KadryA.M. IbrahimT.M. BekhitS.A. AmagaseK. El-SaghierA.M.M. Synthesis and antimicrobial activity of some novel 1,2-dihydro-[1,2,4]triazolo[1,5-a]pyrimidines bearing amino acid moiety.RSC Advances20211152905291610.1039/D0RA08189B 35424245
    [Google Scholar]
73. DesenkoS.M. GorobetsM.Y. LipsonV.V. SakhnoY.I. ChebanovV.A. Dihydroazolopyrimidines: Past, present and perspectives in synthesis, green chemistry and drug discovery.Chem. Rec.2023e20230024410.1002/tcr.202300244 37668291
    [Google Scholar]
74. ChebanovV.A. DesenkoS.M. LipsonV.V. GorobetsN.Y. Multicomponent‐switched reactions in synthesis of heterocycles. In: Multicomponent Reactions towards Heterocycles.John Wiley Sons202110.1002/9783527832439.ch8
    [Google Scholar]
75. SutherlandD.R. TennantG. The chemistry of polyazaheterocyclic compounds. Part V. The synthesis and reactivity of the v-triazolo[3,4-a]pyrimidine ring system.J. Chem. Soc. C197102156216210.1039/j39710002156
    [Google Scholar]
76. BensonF.R. SavellW.L. The chemistry of the vicinal triazoles.Chem. Rev.195046116810.1021/cr60143a001
    [Google Scholar]
77. ShaabaniA. SeyyedhamzehM. GanjiN. Hamidzad SangachinM. ArmaghanM. One-pot four-component synthesis of highly substituted [1,2,4]triazolo[1,5-a]pyrimidines.Mol. Divers.201519470971510.1007/s11030‑015‑9604‑4
    [Google Scholar]
78. TamatamR. KimS.H. ShinD. Transition-metal-catalyzed synthesis of quinazolines: A review.Front Chem.202311114056210.3389/fchem.2023.1140562 37007059
    [Google Scholar]
79. JenaS. ChandaK. Copper catalyzed synthesis of heterocyclic molecules via C-N and C-O bond formation under microwaves: A mini-review.ACS Omega2023826232402325610.1021/acsomega.3c02041 37426233
    [Google Scholar]
80. ChangY. XieC. LiuH. HuangS. WangP. QinW. YanH. Organocatalytic atroposelective construction of axially chiral N, N- and N, S-1,2-azoles through novel ring formation approach.Nat. Commun.2022131193310.1038/s41467‑022‑29557‑1 35410417
    [Google Scholar]
81. HezarcheshmehN.K. GodarzbodF. AbdullahM.N. HossainiZ. Green preparation of new pyrimidine triazole derivatives via one-pot multicomponent reactions of guanidine.Mol. Divers.202428121722810.1007/s11030‑023‑10754‑z 37943418
    [Google Scholar]
82. BadreyM.G. GomhaS.M. ZakiM.E.A. FaragB. El-ReedyA.A.M. Cyanauric chloride as a key precursor and a core component for three-armed triazolopyrimidines: Recent finding about SARs and docking analyses.Results in Chemistry2024710133710.1016/j.rechem.2024.101337
    [Google Scholar]
83. FrizzoC.P. ScapinE. MarzariM.R.B. MünchenT.S. ZanattaN. BonacorsoH.G. BuriolL. MartinsM.A.P. Ultrasound irradiation promotes the synthesis of new 1,2,4-triazolo[1,5-a]pyrimidine.Ultrason. Sonochem.201421395896210.1016/j.ultsonch.2013.12.007
    [Google Scholar]
84. El-mahdy MK. M El-kazakA. A simple synthesis and antimicrobial activity of some new 1,2,4-triazolopyrimidine derivatives.Heterocycles2021102473110.3987/COM‑21‑14409
    [Google Scholar]
85. KamalR. KumarR. KumarV. BhardwajJ.K. SarafP. KumarA. PanditK. KaurS. ChettiP. BeuraS. Diacetoxy iodobenzene mediated regioselective synthesis and characterization of novel [1,2,4]triazolo[4,3-a]pyrimidines: apoptosis inducer, antiproliferative activities and molecular docking studies.J. Biomol. Struct. Dyn.202139124398441410.1080/07391102.2020.1777900 32552396
    [Google Scholar]
86. SoniR. AnejaD.K. SihagM. RaniN. KingerM. On water synthesis of 3-aryl-5,7-dimethyl-1,2,4-triazolo[4,3-a]pyrimidines using iodobenzene diacetate.Lett. Org. Chem.202320540140610.2174/1570178620666221025160300
    [Google Scholar]
87. DarapourZ. ShiriA. Synthesis of new derivatives of Alkylselanyl[1,2,4]triazolo[4,3‐a]pyrimidine as selenium‐containing heterocyclic system.J. Heterocycl. Chem.20236061047105710.1002/jhet.4650
    [Google Scholar]
88. AliwainiS. Abu ThaherB. Al-MasriI. ShurrabN. El-KurdiS. SchollmeyerD. QeshtaB. GhunaimM. CsukR. LauferS. KaiserL. DeignerH.P. Design, synthesis and biological evaluation of novel pyrazolo[1,2,4]triazolopyrimidine derivatives as potential anticancer agents.Molecules20212613406510.3390/molecules26134065 34279406
    [Google Scholar]
89. MuhammadZ.A. FarghalyT.A. AlthagafiI. Al-HussainS.A. ZakiM.E.A. HarrasM.F. Synthesis of antimicrobial azoloazines and molecular docking for inhibiting COVID‐19.J. Heterocycl. Chem.20215861286130110.1002/jhet.4257 34230687
    [Google Scholar]
90. PogakuV. KrishnanR. BasavojuS. Synthesis and biological evaluation of new benzo[d][1,2,3]triazol-1-yl-pyrazole-based dihydro-[1,2,4]triazolo[4,3-a]pyrimidines as potent antidiabetic, anticancer and antioxidant agents.Res. Chem. Intermed.202147255157110.1007/s11164‑020‑04285‑7
    [Google Scholar]
91. TangM.L. WenZ.H. WangJ.H. WangM.L. ZhangH. LiuX.H. JinL. ChangJ. Discovery of pyridone-substituted triazolopyrimidine dual A2A/A1AR antagonists for the treatment of ischemic stroke.ACS Med. Chem. Lett.202213343644210.1021/acsmedchemlett.1c00599 35295085
    [Google Scholar]
92. ChinnamA.K. StaplesR.J. ShreeveJ.M. Synthesis and energetic properties of trifluoromethyl-substituted 2-nitro-[1,2,4]triazolo[1,5-a]pyrimidine derivatives.J. Fluor. Chem.202124510974310.1016/j.jfluchem.2021.109743
    [Google Scholar]
93. PismataroM.C. FelicettiT. BertagninC. NiziM.G. BonominiA. BarrecaM.L. CecchettiV. JochmansD. De JongheS. NeytsJ. LoregianA. TabarriniO. MassariS. 1,2,4-Triazolo[1,5-a]pyrimidines: Efficient one-step synthesis and functionalization as influenza polymerase PA-PB1 interaction disruptors.Eur. J. Med. Chem.202122111349410.1016/j.ejmech.2021.113494 33962311
    [Google Scholar]
94. SongM. ZhaoW. ZhuY. LiuW. DengX. HuangY. Design, synthesis, and evaluation of anticonvulsant activities of new triazolopyrimidine derivatives.Front Chem.20221092528110.3389/fchem.2022.925281 35815216
    [Google Scholar]
95. OlivaP. RomagnoliR. CacciariB. ManfrediniS. PadroniC. BrancaleA. FerlaS. HamelE. CoralloD. AveicS. MilanN. MariottoE. ViolaG. BortolozziR. Synthesis and biological evaluation of highly active 7-anilino triazolopyrimidines as potent antimicrotubule agents.Pharmaceutics2022146119110.3390/pharmaceutics14061191 35745764
    [Google Scholar]
96. FedotovV.V. SavateevK.V. UlomskyE.N. DrokinR.A. SlepukhinP.A. RusinovV.L. 2-Furyl-6-nitro-1,2,4-triazolo[1,5-a]pyrimidin-7-one.Molbank202320231M156310.3390/M1563
    [Google Scholar]
97. HuoX. MaY. ChenZ. YuanL. ZhengX. LiX. Fengting; Liang; You, W.; Zhao, P. One‐pot, multi‐component synthesis of novel 2‐amino‐[1,2,4]triazolo[1,5‐a]pyrimidine‐6‐carboxamide derivatives as antiproliferative agents.ChemistrySelect20216184562456510.1002/slct.202100985
    [Google Scholar]
98. BayazeedA.A. AlnomanR.B. Synthesis of polyheterocyclic ring systems included triazolo[1,5-a]pyrimidine as antioxidant agents.Polycycl. Aromat. Compd.202242373574810.1080/10406638.2020.1750042
    [Google Scholar]
99. MohamedH.S. AminN.H. El-SaadiM.T. Abdel-RahmanH.M. Design, synthesis, biological assessment, and in-silico studies of 1,2,4-triazolo[1,5-a]pyrimidine derivatives as tubulin polymerization inhibitors.Bioorg. Chem.202212110568710.1016/j.bioorg.2022.105687 35196595
    [Google Scholar]
100. RomagnoliR. OlivaP. PrencipeF. ManfrediniS. BudassiF. BrancaleA. FerlaS. HamelE. CoralloD. AveicS. ManfredaL. MariottoE. BortolozziR. ViolaG. Design, synthesis and biological investigation of 2-anilino triazolopyrimidines as tubulin polymerization inhibitors with anticancer activities.Pharmaceuticals (Basel)2022158103110.3390/ph15081031 36015179
     [Google Scholar]
101. KaramiS. BayatM. NasriS. MirzaeiF. A three-component cyclocondensation reaction for the synthesis of new triazolo[1,5-a]pyrimidine scaffolds using 3-aminotriazole, aldehydes and ketene N,S-acetal.Mol. Divers.20212542053206210.1007/s11030‑020‑10096‑0 32388702
     [Google Scholar]
102. LyapustinD.N. UlomskyE.N. BalyakinI.A. ShchepochkinA.V. RusinovV.L. ChupakhinO.N. Oxidative aromatization of 4,7-dihydro-6-nitroazolo[1,5-a]pyrimidines: synthetic possibilities and limitations, mechanism of destruction, and the theoretical and experimental substantiation.Molecules20212616471910.3390/molecules26164719 34443304
     [Google Scholar]
103. KhattabR. SwelmS. KhalilA. Elsayed AbdelhamidA. SolimanA. El-SayedA. Novel sono-synthesized triazole derivatives conjugated with selenium nanoparticles for cancer treatment.Egypt. J. Chem.20216484675468810.21608/ejchem.2021.81154.4018
     [Google Scholar]
104. DattaK. MitraB. SharmaB.S. GhoshP. One‐pot three‐component solvent‐free tandem annulations for synthesis of tetrazolo[1,2‐a]pyrimidine and [1,2,4]triazolo[1,5‐a]pyrimidine.ChemistrySelect202277e202103e20260210.1002/slct.202103602
     [Google Scholar]
105. Ben HassenM. MsalbiD. JismyB. ElghaliF. AifaS. AllouchiH. AbarbriM. ChabchoubF. Three component one-pot synthesis and antiproliferative activity of new [1,2,4]Triazolo[4,3-a]pyrimidines.Molecules2023289391710.3390/molecules28093917 37175327
     [Google Scholar]
106. NasirmahaleL.N. ShiriniF. BayatY. MazloumiM. Solvent-free synthesis of imidazo[1,2-a]pyrimidine-3-carbonitriles and 1,2,4-triazolo[4,3-a]pyrimidines under the catalytic performance of TiO2-[bip]-NH2+ C(NO2)3- as a novel nanocatalyst.J. Mol. Struct.2023127213421010.1016/j.molstruc.2022.134210
     [Google Scholar]
107. NazariS. ZabihzadehM. ShiriniF. TajikH. A Dicationic molten salt catalyzed synthesis of 1,2,4-triazolopyrimidine, quinazolinone and biscoumarin derivatives under green conditions.Polycycl. Aromat. Compd.20234321524153510.1080/10406638.2022.2030765
     [Google Scholar]
108. ReniersF. AnthonissenS. Van MeerveltL. DehaenW. Three-step synthetic pathway toward fully decorated [1,2,3]triazolo[4,5-d]pyrimidine (8-azapurine) derivatives.Org. Lett.202325162820282410.1021/acs.orglett.3c00729 37067154
     [Google Scholar]
109. SavateevK.V. SlepukhinP.A. KotovskayaS.K. CharushinV.N. RusinovV.L. ChupakhinO.N. Atom-efficient synthesis of hybrid molecules combining fragments of triazolopyrimidines and 3-ethoxycarbonyl-1-ethyl-6-fluoroquinolin-4(1H)-one through 1,2,3-triazole linker.Chem. Heterocycl. Compd.202157214315310.1007/s10593‑021‑02886‑7
     [Google Scholar]